The aim of this study is to evaluate the effects of a specialized oral nutritional supplement (SF) enriched with BCAAs, omega-3 fatty acids, and dietary fiber on improving the nutritional status of dialysis patients with mild to moderate malnutrition, and thereby alleviating fatigue and enhancing quality of life. We will assess various aspects of protein-energy wasting (PEW), as well as changes in the Malnutrition Inflammation Score (MIS), Geriatric Nutritional Risk Index (GNRI), fatigue, appetite, serum BCAA levels, uremic toxins, and gut microbiota composition.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Malnutrition Inflammation Score (MIS)
Timeframe: From enrollment to the end of treatment at 12 weeks
Change in Geriatric Nutritional Risk Index (GNRI)
Timeframe: From enrollment to the end of treatment at 12 weeks
Change in serum albumin concentration
Timeframe: From enrollment to end of treatment (12 weeks)
Change in serum pre-albumin concentration
Timeframe: From enrollment to end of treatment (12 weeks)
Change in Protein-Energy Wasting (PEW) status
Timeframe: From enrollment to end of treatment (12 weeks)
Change in body composition
Timeframe: From enrollment to end of treatment (12 weeks)